21 CFR § 862.2270 - Thin-layer chromatography system for clinical use.

---
identifier: "/us/cfr/t21/s862.2270"
source: "ecfr"
legal_status: "authoritative_unofficial"
title: "21 CFR § 862.2270 - Thin-layer chromatography system for clinical use."
title_number: 21
title_name: "Food and Drugs"
section_number: "862.2270"
section_name: "Thin-layer chromatography system for clinical use."
chapter_name: "FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES"
subchapter_number: "H"
subchapter_name: "MEDICAL DEVICES"
part_number: "862"
part_name: "CLINICAL CHEMISTRY AND CLINICAL TOXICOLOGY DEVICES"
positive_law: false
currency: "2026-04-05"
last_updated: "2026-04-05"
format_version: "1.1.0"
generator: "[email protected]"
authority: "21 U.S.C. 351, 360, 360c, 360e, 360j, 360 371."
regulatory_source: "52 FR 16122, May 1, 1987, unless otherwise noted."
cfr_part: "862"
---


# 862.2270 Thin-layer chromatography system for clinical use.

(a) *Identification.* A thin-layer chromatography (TLC) system for clinical use is a device intended to separate one or more drugs or compounds from a mixture. The mixture of compounds is absorbed onto a stationary phase or thin layer of inert material (e.g., cellulose, alumina, etc.) and eluted off by a moving solvent (moving phase) until equilibrium occurs between the two phases.

(b) *Classification.* Class I (general controls). The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to § 862.9. Particular components of TLC systems, *i.e.,* the thin-layer chromatography apparatus, TLC atomizer, TLC developing tanks, and TLC ultraviolet light, are exempt from the current good manufacturing practice requirements of the quality management system regulation in part 820 of this chapter, except for requirements concerning records and complaint files under § 820.35 of this chapter.

[52 FR 16122, May 1, 1987, as amended at 65 FR 2309, Jan. 14, 2000; 90 FR 55980, Dec. 4, 2025]